These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22156047)

  • 1. Methods for analysis of amyloid-β aggregates.
    Bruggink KA; Müller M; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2012; 28(4):735-58. PubMed ID: 22156047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Aβ aggregation state by atomic force microscopy.
    Legleiter J
    Methods Mol Biol; 2011; 670():57-70. PubMed ID: 20967583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of mass spectrometry to study amyloid-β peptides.
    Grasso G
    Mass Spectrom Rev; 2011; 30(3):347-65. PubMed ID: 21500241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy.
    Serem WK; Bett CK; Ngunjiri JN; Garno JC
    Microsc Res Tech; 2011 Jul; 74(7):699-708. PubMed ID: 21698718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
    Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
    Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput monitoring of amyloid-β(42) assembly into soluble oligomers achieved by sensitive conformation state-dependent immunoassays.
    Zhao WQ; Toolan D; Hepler RW; Wolfe AL; Yu Y; Price E; Uebele VN; Schachter JB; Reynolds IJ; Renger JJ; McCampbell A; Ray WJ
    J Alzheimers Dis; 2011; 25(4):655-69. PubMed ID: 21483096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ measurement by enzyme-linked immunosorbent assay.
    Schmidt SD; Mazzella MJ; Nixon RA; Mathews PM
    Methods Mol Biol; 2012; 849():507-27. PubMed ID: 22528112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulations of low-ordered alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers.
    Zhao J; Wang Q; Liang G; Zheng J
    Langmuir; 2011 Dec; 27(24):14876-87. PubMed ID: 22077332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and methodological complexities of beta-amyloid peptide: Implications for Alzheimer's disease research.
    Matuszyk MM; Garwood CJ; Ferraiuolo L; Simpson JE; Staniforth RA; Wharton SB
    J Neurochem; 2022 Feb; 160(4):434-453. PubMed ID: 34767256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
    Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
    Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein engineering to stabilize soluble amyloid β-protein aggregates for structural and functional studies.
    Härd T
    FEBS J; 2011 Oct; 278(20):3884-92. PubMed ID: 21824290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrillizing agents catalyze the formation of unstable intermediate aggregates of beta-amyloid.
    Wang MS; Boddapati S; Sierks MR
    Biotechnol Prog; 2010; 26(4):1172-9. PubMed ID: 20306540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.
    Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A
    Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
    Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
    Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.